For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Currently, no HIV-1 envelope glycoprotein (Env) subunit vaccine can induce antibodies (Abs) of the quality and quantity required for providing protective immunity. Gözde Işık's research focuses on designing chimeric proteins, containing Env fused to costimulatory molecules, with the aim of simultaneously activating specific immune cells with Env and a constimulatory molecule in order to achieve enhanced Env immunogenicity.

Event details of Antibodies against HIV-1
Date 26 September 2014
Time 12:00 -13:00
Location Agnietenkapel

G.Işık, HIV-1 Envelope Glycoproteins with Costimulatory Domains for Vaccine Applications.

Supervisor

Prof. B. Berkhout

Co-supervisor

Dr R.W. Sanders

Agnietenkapel

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.